Session Title: New global initiatives to improve access and quality of essential medicines for childhood cancer
Date/Time: 16.30-18.30 GMT (London), Thursday 15th Nov 2022
Hosted by the International Society of Paediatric Oncology (SIOP) and World Child Cancer UK
- Jon Rosser, UK (CEO, WCC-UK)
- Kathy Pritchard-Jones, UK (immediate past-President, SIOP and Professor of Paediatric Oncology at University College London)
Many essential drugs needed to treat children with cancer are not available to hospitals in low and middle income countries.
This is a major problem with over 50% of essential drugs not available meaning children aren’t having the best treatment causing unnecessary deaths, longer stays in hospitals, and more side effects.
Hear about the work being done by NGOs, pharmaceuticals, institutions, WHO, and clinicians to help resolve this problem at a global and local level.
This interactive session with expert presenters will:
- Discuss new initiatives to improve uninterrupted and affordable provision of high quality essential medicines needed to treat children with cancer.
- Present examples from children’s hospitals in Malawi and Cameroon. What do these shortages mean to families, and how World Child Cancer are providing practical help.
- Show how the new initiatives fit together and how collaboration is the key to success and helping reduce the gap between the high income countries and the rest of world.
- Include a panel discussion of clinicians, activists, representatives from key players in global oncology, with interactive Q&A with the audience.
Simon Bailey (Consultant Paediatric Oncologist at the Great North Children’s Hospital specialising in neuro-oncology and a Professor of Paediatric Neuro-Oncology at Newcastle University, UK)
“The WHO EML for children – how it covers childhood cancers and how to influence its revisions to address evolving needs and therapeutic innovations”
Daniel McKenzie (Childhood Cancer International Board Member and Executive Director of Kidzcan, Zimbabwe)
“What’s the problem we are trying to solve and how do we work around it now?”
Andre Ilbawi (WHO Cancer Control Officer, Switzerland)
“Global Platform for Access to Childhood Cancer Medicines”
Cary Adams (Chief Executive Officer, Union for International Cancer Control (UICC), Switzerland/UK)
UICC Access to Oncology Medicines (ATOM) Coalition
Adele Paterson (Chief Executive Officer, International Health Partners, UK)
Motivation for a humanitarian relief organisation to move into children’s oncology drugs including example of how they work with World Child Cancer
George Chagaluka (Paediatric Oncologist, Queen Elizabeth Central Hospital (QECH) Blantyre, Malawi)
Example of how reliable access to high quality medicines is an integral component of improving childhood cancer care
Francine Kouya (Medical Doctor & Oncology Supervisor, Cameroon Baptist Convention, Cameroon)
“Impact of working under chronic crisis”
Followed by a Panel Discussion